Global Standard Lancets Market Research Report 2021

1 Standard Lancets Market Overview

• 1.1 Product Overview and Scope of Standard Lancets
• 1.2 Standard Lancets Segment by Type
  • 1.2.1 Global Standard Lancets Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Needle
  • 1.2.3 Blade
• 1.3 Standard Lancets Segment by Application
  • 1.3.1 Standard Lancets Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospitals and Clinics
  • 1.3.3 Homecare Settings
  • 1.3.4 Others
• 1.4 Global Standard Lancets Market Size Estimates and Forecasts
  • 1.4.1 Global Standard Lancets Revenue 2016-2027
  • 1.4.2 Global Standard Lancets Sales 2016-2027
  • 1.4.3 Standard Lancets Market Size by Region: 2016 Versus 2021 Versus 2027

2 Standard Lancets Market Competition by Manufacturers

• 2.1 Global Standard Lancets Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Standard Lancets Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Standard Lancets Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Standard Lancets Manufacturing Sites, Area Served, Product Type
• 2.5 Standard Lancets Market Competitive Situation and Trends
  • 2.5.1 Standard Lancets Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Standard Lancets Players Market Share by Revenue
  • 2.5.3 Global Standard Lancets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Standard Lancets Retrospective Market Scenario by Region

• 3.1 Global Standard Lancets Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Standard Lancets Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Standard Lancets Market Facts & Figures by Country
  • 3.3.1 North America Standard Lancets Sales by Country
  • 3.3.2 North America Standard Lancets Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Standard Lancets Market Facts & Figures by Country
  • 3.4.1 Europe Standard Lancets Sales by Country
  • 3.4.2 Europe Standard Lancets Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Standard Lancets Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Standard Lancets Sales by Region
  • 3.5.2 Asia Pacific Standard Lancets Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Standard Lancets Market Facts & Figures by Country
  • 3.6.1 Latin America Standard Lancets Sales by Country
  • 3.6.2 Latin America Standard Lancets Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Standard Lancets Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Standard Lancets Sales by Country
  • 3.7.2 Middle East and Africa Standard Lancets Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Standard Lancets Historic Market Analysis by Type

• 4.1 Global Standard Lancets Sales Market Share by Type (2016-2021)
• 4.2 Global Standard Lancets Revenue Market Share by Type (2016-2021)
• 4.3 Global Standard Lancets Price by Type (2016-2021)

5 Global Standard Lancets Historic Market Analysis by Application

• 5.1 Global Standard Lancets Sales Market Share by Application (2016-2021)
• 5.2 Global Standard Lancets Revenue Market Share by Application (2016-2021)
• 5.3 Global Standard Lancets Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Roche
  • 6.1.1 Roche Corporation Information
  • 6.1.2 Roche Description and Business Overview
  • 6.1.3 Roche Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Roche Product Portfolio
  • 6.1.5 Roche Recent Developments/Updates
• 6.2 Lifescan
  • 6.2.1 Lifescan Corporation Information
  • 6.2.2 Lifescan Description and Business Overview
  • 6.2.3 Lifescan Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Lifescan Product Portfolio
  • 6.2.5 Lifescan Recent Developments/Updates
• 6.3 BD
  • 6.3.1 BD Corporation Information
  • 6.3.2 BD Description and Business Overview
  • 6.3.3 BD Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 BD Product Portfolio
  • 6.3.5 BD Recent Developments/Updates
• 6.4 Bayer
  • 6.4.1 Bayer Corporation Information
  • 6.4.2 Bayer Description and Business Overview
  • 6.4.3 Bayer Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Bayer Product Portfolio
  • 6.4.5 Bayer Recent Developments/Updates
• 6.5 Abbott
  • 6.5.1 Abbott Corporation Information
  • 6.5.2 Abbott Description and Business Overview
  • 6.5.3 Abbott Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Abbott Product Portfolio
  • 6.5.5 Abbott Recent Developments/Updates
• 6.6 B. Braun
  • 6.6.1 B. Braun Corporation Information
  • 6.6.2 B. Braun Description and Business Overview
  • 6.6.3 B. Braun Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 B. Braun Product Portfolio
  • 6.6.5 B. Braun Recent Developments/Updates
• 6.7 ARKRAY
  • 6.6.1 ARKRAY Corporation Information
  • 6.6.2 ARKRAY Description and Business Overview
  • 6.6.3 ARKRAY Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 ARKRAY Product Portfolio
  • 6.7.5 ARKRAY Recent Developments/Updates
• 6.8 Terumo
  • 6.8.1 Terumo Corporation Information
  • 6.8.2 Terumo Description and Business Overview
  • 6.8.3 Terumo Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Terumo Product Portfolio
  • 6.8.5 Terumo Recent Developments/Updates
• 6.9 I-SENS
  • 6.9.1 I-SENS Corporation Information
  • 6.9.2 I-SENS Description and Business Overview
  • 6.9.3 I-SENS Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 I-SENS Product Portfolio
  • 6.9.5 I-SENS Recent Developments/Updates
• 6.10 Nipro
  • 6.10.1 Nipro Corporation Information
  • 6.10.2 Nipro Description and Business Overview
  • 6.10.3 Nipro Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Nipro Product Portfolio
  • 6.10.5 Nipro Recent Developments/Updates
• 6.11 Omron
  • 6.11.1 Omron Corporation Information
  • 6.11.2 Omron Standard Lancets Description and Business Overview
  • 6.11.3 Omron Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Omron Product Portfolio
  • 6.11.5 Omron Recent Developments/Updates
• 6.12 Infopia
  • 6.12.1 Infopia Corporation Information
  • 6.12.2 Infopia Standard Lancets Description and Business Overview
  • 6.12.3 Infopia Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Infopia Product Portfolio
  • 6.12.5 Infopia Recent Developments/Updates
• 6.13 AgaMatrix
  • 6.13.1 AgaMatrix Corporation Information
  • 6.13.2 AgaMatrix Standard Lancets Description and Business Overview
  • 6.13.3 AgaMatrix Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 AgaMatrix Product Portfolio
  • 6.13.5 AgaMatrix Recent Developments/Updates
• 6.14 Smiths Medical
  • 6.14.1 Smiths Medical Corporation Information
  • 6.14.2 Smiths Medical Standard Lancets Description and Business Overview
  • 6.14.3 Smiths Medical Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Smiths Medical Product Portfolio
  • 6.14.5 Smiths Medical Recent Developments/Updates
• 6.15 Sarstedt
  • 6.15.1 Sarstedt Corporation Information
  • 6.15.2 Sarstedt Standard Lancets Description and Business Overview
  • 6.15.3 Sarstedt Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Sarstedt Product Portfolio
  • 6.15.5 Sarstedt Recent Developments/Updates
• 6.16 SANNUO
  • 6.16.1 SANNUO Corporation Information
  • 6.16.2 SANNUO Standard Lancets Description and Business Overview
  • 6.16.3 SANNUO Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 SANNUO Product Portfolio
  • 6.16.5 SANNUO Recent Developments/Updates
• 6.17 Yicheng
  • 6.17.1 Yicheng Corporation Information
  • 6.17.2 Yicheng Standard Lancets Description and Business Overview
  • 6.17.3 Yicheng Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Yicheng Product Portfolio
  • 6.17.5 Yicheng Recent Developments/Updates
• 6.18 Yuwell
  • 6.18.1 Yuwell Corporation Information
  • 6.18.2 Yuwell Standard Lancets Description and Business Overview
  • 6.18.3 Yuwell Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 Yuwell Product Portfolio
  • 6.18.5 Yuwell Recent Developments/Updates
• 6.19 Greiner Bio One
  • 6.19.1 Greiner Bio One Corporation Information
  • 6.19.2 Greiner Bio One Standard Lancets Description and Business Overview
  • 6.19.3 Greiner Bio One Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
  • 6.19.4 Greiner Bio One Product Portfolio
  • 6.19.5 Greiner Bio One Recent Developments/Updates
• 6.20 Edan
  • 6.20.1 Edan Corporation Information
  • 6.20.2 Edan Standard Lancets Description and Business Overview
  • 6.20.3 Edan Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
  • 6.20.4 Edan Product Portfolio
  • 6.20.5 Edan Recent Developments/Updates
• 6.21 Narang Medical
  • 6.21.1 Narang Medical Corporation Information
  • 6.21.2 Narang Medical Standard Lancets Description and Business Overview
  • 6.21.3 Narang Medical Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
  • 6.21.4 Narang Medical Product Portfolio
  • 6.21.5 Narang Medical Recent Developments/Updates

7 Standard Lancets Manufacturing Cost Analysis

• 7.1 Standard Lancets Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Standard Lancets
• 7.4 Standard Lancets Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Standard Lancets Distributors List
• 8.3 Standard Lancets Customers

9 Standard Lancets Market Dynamics

• 9.1 Standard Lancets Industry Trends
• 9.2 Standard Lancets Growth Drivers
• 9.3 Standard Lancets Market Challenges
• 9.4 Standard Lancets Market Restraints

10 Global Market Forecast

• 10.1 Standard Lancets Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Standard Lancets by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Standard Lancets by Type (2022-2027)
• 10.2 Standard Lancets Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Standard Lancets by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Standard Lancets by Application (2022-2027)
• 10.3 Standard Lancets Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Standard Lancets by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Standard Lancets by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List